아시아 태평양 오메가-3 성분 의약품 시장 – 2030년까지의 산업 동향 및 예측

아시아 태평양 오메가-3 성분 제약 시장 분석 및 규모

오메가-3 성분으로 구성된 건강한 식단에 대한 소비자 선호도의 경향과 동남아시아에서 생선 기름의 광범위한 사용은 아시아 태평양 지역의 오메가-3 판매를 개선할 것으로 예상됩니다. 현재, 여러 제조업체가 의약품을 위한 새롭고 혁신적인 오메가-3 성분을 개발할 수 있는 경쟁 우위를 창출할 것으로 예상되는 수많은 연구가 진행 중입니다. 아시아 태평양 지역에서 라이프스타일과 연령 관련 질병이 증가함에 따라 보충제 및 기능성 식품 부문의 성장이 개선되고 있으며 매출 점유율은 52%입니다.

Data Bridge Market Research는 2023-2030년 예측 기간 동안 제약 시장을 위한 오메가-3 성분의 성장률을 분석합니다. 해당 예측 기간 동안 제약 시장을 위한 오메가-3 성분의 예상 CAGR은 약 12.5%입니다. 시장은 2022년에 1억 1,550만 달러로 평가되었으며, 2030년까지 2억 9,635만 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

아시아 태평양 오메가-3 성분 제약 시장 범위 및 세분화

Market Definition

Omega 3 ingredients are naturally occurring polyunsaturated fatty acids and nutrients that are essential for optimal human health. There are three kinds of omega 3 ingredients, namely, eicosapentaenoic acid (EPA), alpha-linoleic acid (ALA), and docosahexaenoic acid (DHA). EPA and DHA are mostly extracted from fish and ALA is mainly extracted from plants sources such as seeds and nuts.

Asia-Pacific Omega-3 Ingredients for Pharmaceuticals Market Dynamics

Drivers

• Increasing Demand of Infants Formula

This growing demand for infant nutrition is boosting the omega-3 market in Asia-Pacific region. China and India are the world’s largest consumers of infant formula products because of high birth rates in the countries. In 2015, China resulted for about one-third of the infant formula market, while infant formula is also the largest segment of baby food in India, where an annual average of childbirth is more than 25 million children. The growing demand for high-nutritional food for infants in the developed and developing economies of Asia, such as China and India led to the further increase in the consumption of omega-3 products which in turn is estimated to increase the growth in the region. Thus, this factor increases the growth of the market.

• Rising Technological Advancements

Technological advancements and product innovation is anticipated to boost the market for omega 3 ingredients during the forecast period. For instance, DSM introduced new 3C technology to reinvigorate omega 3 supplements category on October 6, 2016. Furthermore, on June 9, 2015, Croda introduced Incromega DHA and approved by European Food Safety Authority (EFSA). Additionally, Royal DSM collaborated with Evonik to manufacture omega 3 fatty acid products from natural marine algae for animal nutrition on March 8, 2017. This innovation will allow the production of omega 3 fatty acids for animal nutrition without using fish oil. This factor improves the market growth.

Opportunities

• Huge growth in concentrated forms of algal omega-3 ingredients

New ultra-high concentrated omega-3 ingredients offer several benefits to consumers willing to pay a higher premium price for high-end products. Several suppliers are investing in the production of high concentrated algal omega-3 products, estimating increased demand to drive the sales. The market for concentrates has also been increasing, as more consumers become aware of the benefits of algal omega-3 and seek the benefits of higher doses. Several major companies are involved in omega-3 manufacturing that has started to strategically capitalize the existing business expansion opportunity.

• Rising Demand of Omega-3 by Elderly Population

There is an increasing focus on healthy aging with good physical and mental function that is boosting the growth of the market. Countries, such as Japan, are experiencing a "super-aging" society in rural and urban areas. As per the 2014 estimates by Bloomberg, around 33.0% of the Japanese population was above the age of 60, 25.9% were aged 65 or above, and 12.5% were aged 75 or above. Increased blood levels of omega-3 fatty acids found in seafood are related with a higher likelihood of healthy aging among older adults. This is leading the manufacturers to develop the varieties of omega-3 ingredients in bulk. Thus, this factor helps to create much opportunities for the growth of the market.

Restraints/Challenges

• Side Effects of omega-3 ingredients

There are various side-effects associated with the omega-3 ingredients for pharmaceuticals. Effects such as burping, diarrhea, heartburn, joint pain, stomach pain or discomfort, vomiting, constipation, nausea. Thus, these adverse effects affect the growth rate by decreasing the adoption of omega-3. This impedes the market growth.

• Increasing Negative Consumer Perception About omega-3 ingredients

Negative consumer perception associated with the smell and taste of omega-3 ingredients is also anticipated to limit the growth of the market. These unstable fatty acids can damage through enzymatic or chemical oxidation to form compounds that give foods a fishy smell. Additionally, fresh fish oil has no fishy taste or smell, just like fresh fish. People feel hesitant to adopt for omega-3 ingredients. Thus, this hampers the market growth.

This omega-3 ingredients for pharmaceuticals market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the omega-3 ingredients for pharmaceuticals market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2021, Omega-3 related supplier GC Rieber VivoMega announced its plans to enhance production facilities and storage tanks to accommodate more ingredients in the upcoming years.
• In 2020, DSM launched a plant-based DHA oil product, DHA SF55-O200DS oil extracted from schizochytrium algae. This product is utilized for enhancing the nutrition in mothers and infants. This new product launch by DSM increased its product portfolio in nutrition business thus, increased demand for its product in the market causes increased revenue in future.

Asia-Pacific Omega-3 Ingredients for Pharmaceuticals Market Scope

The Omega-3 ingredients for pharmaceuticals market is segmented on the basis of source, type, forms, therapeutic areas, population type, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Marine
• Plant

Type

• Docosahexaenoic Acid (DHA)
• Eicosapentaenoic Acid (EPA)
• Alpha-Linolenic Acid (ALA)

Forms

• Liquid
• Dry

Therapeutic Areas

• Cardiovascular Diseases
• Autoimmune Diseases
• Bone & Joint Disorders
• Neurological Disorders
• Ophthalmic Disorders
• Skin Health
• Cancer
• Others

Population Type

• Adults
• Children

Distribution Channel

• Direct
• Indirect

Omega-3 Ingredients for Pharmaceuticals Market Regional Analysis/Insights

The Omega-3 ingredients for pharmaceuticals market is analyzed and market size insights and trends are provided by source, type, forms, therapeutic areas, population type, and distribution channel as referenced above.

The major countries covered in the Omega-3 ingredients for pharmaceuticals market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

중국은 식물성 오메가-3 제품에 대한 소비자 수요 증가로 인해 시장을 선도하고 있습니다. 영아 신경계, 시력 및 뇌 발달에 대한 오메가 3 DHA의 중요성이 커지고 있으며, 이 제품의 장기적인 건강 지원 능력이 향후 몇 년 동안 시장 성장을 견인할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 아시아 태평양 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 아시아 태평양 오메가-3 성분 제약 시장 점유율 분석

제약 시장 경쟁 구도를 위한 오메가-3 성분은 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 아시아 태평양 지역 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 제약 시장용 오메가-3 성분과 관련된 회사의 초점에만 관련이 있습니다.

제약품용 오메가-3 성분 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Avestia Pharma(인도)
• 노바셉(프랑스)
• AbbVie Inc.(미국)
• KD Pharma Group(일본)
• BASF SE(독일)
• 코르비온(네덜란드)
• DSM(네덜란드)
• 아스트라제네카(영국)
• GSK plc. (영국)
• Fresenius Kabi AG(독일)
• 크로다 인터내셔널 주식회사(미국)
• AMARIN CORPORATION (아일랜드)
• ANI Pharmaceuticals, Inc. (미국)
• 에팍스(노르웨이)
• Strides Pharma Science Limited(인도)
• Pharma Marine AS(노르웨이)
• KinOmega Biopharm Inc. (중국)
• 캠버 파마슈티컬스(Camber Pharmaceuticals, Inc.) (미국)

SKU-55583